Skip to Content
menu

Change Life Stories

Kim Living with Hereditary Angioedema

I want people to know they’re not alone.

Read Kim's story

Change Life Stories

Shanna Living with Hereditary Angioedema Type 1

There’s so much uncertainty with rare disease — the best treatment is your own confidence in making the decisions that are right for you.

Read Shanna's story

Change Life Stories

Nancy Living with ATTR Amyloidosis with Polyneuropathy

I look at my dad and think, ‘Is that what’s going to happen to me in the future?’

Read Nancy's story

Change Life Stories

Milton Living with ATTR Amyloidosis with Cardiomyopathy

When I think about memories, I smile. My memories keep me going.

Read Milton's story

News Updates

Intellia Therapeutics Completes Enrollment in Phase 3 MAGNITUDE-2 Trial of Nexiguran Ziclumeran (Nex-z) for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)

Read more

Intellia Therapeutics Announces Upcoming Nexiguran Ziclumeran (nex-z) Medical Congress Presentations

Read more
View all news updates

Aiming to make the impossible, possible

Our
Mission

To transform the lives of people with severe diseases by developing and commercializing potentially curative treatments.

Learn more

Programs
and Pipeline

Each one of us together for patients

Learn more

Join Us

See how you can change life stories with genome editing.

Learn more